United States

Regulatory News - Asias Headlines

BRIEF-Kazia Receives FDA Orphan Designation For Gdc-0084

* KAZIA THERAPEUTICS LTD - PHASE II CLINICAL STUDY OF GDC-0084 IS ANTICIPATED TO PROVIDE AN INITIAL DATA READ-OUT IN EARLY CALENDAR 2019 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)


Democrats' memo charges Republicans trying to undermine Russia probes

WASHINGTON The Democratic minority on the U.S. House of Representatives Intelligence Committee on Saturday released a response to Republican charges that the FBI and Justice Department have abused the law in their investigation of possible ties between Russia and Donald Trump's 2016 presidential campaign. | Video